Tuesday, February 3, 2026
HomeHealthcareAdvocates Applaud DEA’s Fourth Extension of Distant Prescribing Flexibilities

Advocates Applaud DEA’s Fourth Extension of Distant Prescribing Flexibilities

Simply forward of their scheduled expiration, the Drug Enforcement Administration prolonged telemedicine distant prescribing flexibilities for an extra yr, a transfer welcomed by many telehealth advocates.

Flexibilities that allowed for the prescribing of managed substances through telehealth with out an in-person examination have been put in place in the course of the Covid-19 pandemic to broaden entry to care. They have been set to run out on the finish of 2025, however now they’re prolonged by means of December 31, 2026. That is the fourth time these flexibilities have been prolonged.

Within the Federal Registerthe DEA acknowledged that the extension is to forestall sufferers from abruptly shedding entry to care, because the expiration of the flexibilities would drive a return to pre-pandemic restrictions. It’ll additionally present time for the DEA to determine a remaining set of rules, guarantee a easy transition for sufferers and suppliers and supply satisfactory time for suppliers to come back into compliance.

ATA Motion, the advocacy arm of the American Telemedicine Affiliation (ATA), acknowledged that the group is grateful for the extension.

“This one-year extension is a serious aid for sufferers and healthcare suppliers, restoring certainty and avoiding remedy gaps for hundreds of thousands of Individuals. … The distant prescribing of managed substances waiver – initially put in place throughout President Trump’s first time period in workplace and prolonged underneath his management throughout his present time period within the White Home – has confirmed to be a lifeline for sufferers by increasing entry to care, decreasing remedy delays, and enhancing outcomes. This critically necessary waiver have to be preserved constantly till a everlasting coverage is enacted,” stated Alexis Apple, deputy government director of ATA Motion and vice chairman of federal affairs on the ATA, in a press release.

Specifically, the ATA is in favor of a particular registration course of that may enable a clinician to register with a view to just about prescribe managed substances.

“We proceed to assist a everlasting Particular Registration framework that permits accountable affected person care and equips the DEA with acceptable instruments to forestall misuse,” Apple stated. “We additionally encourage the DEA to hunt supplier suggestions when growing safeguards to scale back diversion, enhance entry to important prescriptions for psychological well being, substance use dysfunction, and different power situations, and prioritize affected person security. ATA Motion believes scientific choices ought to stay the judgment of certified medical professionals, supported by regulatory frameworks that shield sufferers and promote accountable care.”

The Alliance for Related Care, one other telehealth advocate, additionally applauded the extension and known as for a everlasting answer.

“We applaud DEA for appearing to proceed entry to take care of the hundreds of thousands of sufferers who rely upon telehealth for important medicines. Nonetheless, this needs to be the final time these Individuals come inside days of shedding entry to therapies they want. We name on DEA to interact stakeholders and develop a everlasting framework to make sure protected entry to prescriptions by means of telehealth,” stated Chris Adamec, government director of the Alliance for Related Care, in a press release.

Picture credit score: Sorbetto, Getty Pictures

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments